Not applicableUnknownNCT05735704What this trial is testingEarly Detection and Screening of Hematological Malignancies - SANGUINEWho this might be right forHematologic Malignancy JaxBio Ltd 3,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06594432What this trial is testingMolecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System InvolvementWho this might be right forDiffuse Large B Cell Lymphoma (DLBCL) The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Study completedNCT01408563What this trial is testingReduced Intensity Double Umbilical Cord Blood TransplantationWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMultiple Myeloma+2 more Massachusetts General Hospital 33
Testing effectiveness (Phase 2)UnknownNCT01279707What this trial is testingMonoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)Who this might be right forRecurrent or Refractory B Cell Acute Lymphoblastic Leukaemia Queen Mary University of London 55
Not applicableLooking for participantsNCT07248163What this trial is testingUniversal CAR-T Cell Therapy for NHLWho this might be right forNon-hodgkin Lymphoma,B Cell Bioray Laboratories 6
Early research (Phase 1)Active Not RecruitingNCT06667687What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma AbbVie 21
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48
Early research (Phase 1)Study completedNCT00077155What this trial is testingCilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT07077512What this trial is testingRelmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell LymphomaWho this might be right forLarge B Cell Diffuse LymphomaMantle Cell Lymphoma (MCL)Follicular Lymphoma ( FL) Sun Yat-sen University 30
Very early researchLooking for participantsNCT06693973What this trial is testingAn Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forB-cell Non-Hodgkin Lymphoma (B-NHL) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Testing effectiveness (Phase 2)Looking for participantsNCT04502394What this trial is testingSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLLWho this might be right forDiffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Kartos Therapeutics, Inc. 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652139What this trial is testingSelinexor Combined With BEAM for ASCT in R/R DLBCL With MYC PositiveWho this might be right forDiffuse Large B Cell Lymphoma Ruijin Hospital 82
Testing effectiveness (Phase 2)Study completedNCT01775475What this trial is testingIntravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin LymphomaWho this might be right forAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+6 more AIDS Malignancy Consortium 7
Early research (Phase 1)Study completedNCT03955783What this trial is testingVenetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic MalignanciesWho this might be right forDiffuse Large B-cell LymphomaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma Sanjay Mohan 78
Early research (Phase 1)UnknownNCT04684472What this trial is testingModified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell MalignanciesWho this might be right forRefractory B-Cell Non-Hodgkin LymphomaRefractory Leukemia Liqun Zou 18
Early research (Phase 1)Study completedNCT03886831What this trial is testingPRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesWho this might be right forRelapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more Prelude Therapeutics Incorporated 232
Testing effectiveness (Phase 2)Study completedNCT00003402What this trial is testingPeripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma University of Maryland, Baltimore 35
Testing effectiveness (Phase 2)Study completedNCT03992339What this trial is testingEvaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Antengene Corporation 60
Testing effectiveness (Phase 2)Study completedNCT00003039What this trial is testingFlavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01754857What this trial is testingBendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLLWho this might be right forLymphoid LeukemiaSmall Lymphocytic LymphomaLymphoma, Non-Hodgkin University of Wisconsin, Madison 36